United States

US v. Okechukwu Dimkpa - Affirmation of Conviction

The Fourth Circuit affirmed a district court's denial of a physician's motion to vacate his conviction for unlawfully distributing oxycodone. The court found that the defendant procedurally defaulted his claim, which was based on a subsequent Supreme Court ruling regarding the mens rea requirement for such offenses, and did not demonstrate sufficient cause to overcome this default.

US v. Cory Currie - Criminal Appeal

The Fourth Circuit Court of Appeals dismissed in part and affirmed in part the appeal of Cory Fernando Currie. The court granted the government's motion to dismiss the appeal based on the appeal waiver in Currie's plea agreement, finding the district court conducted a proper Rule 11 hearing.

Christopher Martin v. Joseph Walters - Appeal Dismissal

The Fourth Circuit Court of Appeals dismissed Christopher James Martin's appeal of a district court's order. The court denied Martin's request for a certificate of appealability, finding he did not make the requisite showing of a denial of a constitutional right.

Courtney Boyd v. United States - Compassionate Release Appeal Denied

The Fourth Circuit Court of Appeals affirmed a district court's denial of Courtney Omar Boyd's motion for compassionate release. The court found no abuse of discretion in the district court's determination that Boyd failed to demonstrate extraordinary and compelling reasons for release.

Brandon Thompson Appeal Dismissed by Fourth Circuit

The Fourth Circuit Court of Appeals dismissed Brandon J. Thompson's appeal of a district court order denying his motion for relief under 28 U.S.C. § 2255. The court found that Thompson failed to make the requisite showing for a certificate of appealability, thus denying the appeal.

FDA Warning Letter to John Yoder Farm

The FDA issued a warning letter to John Yoder Farm for serious violations of the Shell Egg Regulation (21 CFR Part 118) and the FD&C Act. The farm failed to implement a written Salmonella Enteritidis Prevention Plan and had other insanitary conditions. The FDA is concerned about the compliance status and potential health risks.

FDA Warning Letter to Kare Solutions LLC dba Zappy

The FDA issued a warning letter to Kare Solutions LLC dba Zappy for misbranding compounded drug products, including semaglutide, tirzepatide, and liraglutide. The agency found that Zappy's website made false or misleading claims about these products, suggesting they were FDA-approved or compounded by Zappy when they were not.

FDA Warning Letter to GenoGenix LLC

The FDA issued a warning letter to GenoGenix LLC for serious deficiencies in drug production practices, including failures to meet conditions for outsourcing facilities and insanitary conditions. The company has ceased production and initiated a voluntary recall of drug products.

FDA Warning Letter to Beta Bionics, Inc.

The FDA issued a warning letter to Beta Bionics, Inc. regarding violations of the Quality System Regulation for their iLet Dosing Decision Software and iLet ACE Pump. The letter details failures in corrective and preventive action procedures, including inadequate analysis of complaints leading to serious adverse health outcomes.

FDA Warning Letter to Diasol, Inc. for Medical Device Violations

The FDA issued a warning letter to Diasol, Inc. for manufacturing unapproved and misbranded medical devices, specifically disinfectants for hemodialysis systems. The company also violated Quality System Regulation requirements. The FDA has requested corrective actions to ensure compliance.